Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Avadel Pharmaceuticals Plc ADR (AVDL)

Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avadel Pharmaceuticals Plc ADR 10 EARLSFORT TERRACE DUBLIN L2 D02 T380 IRL

www.avadel.com Employees: 154 P: 353-1901-5201

Description:

Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.

Key Statistics

Overview:

Market Capitalization, $K 994,456
Enterprise Value, $K 963,336
Shares Outstanding, K 96,362
Annual Sales, $ 27,960 K
Annual Net Income, $ -160,280 K
Last Quarter Sales, $ 50,030 K
Last Quarter Net Income, $ -2,630 K
EBIT, $ -64,010 K
EBITDA, $ -62,240 K
60-Month Beta 1.32
% of Insider Shareholders 4.80%
% of Institutional Shareholders 69.19%
Float, K 91,737
% Float 95.20%
Short Volume Ratio 0.53

Growth:

1-Year Return -25.71%
3-Year Return 37.23%
5-Year Return 71.71%
5-Year Revenue Growth -72.93%
5-Year Earnings Growth 6.03%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -0.79
EPS Growth vs. Prev Qtr 78.57%
EPS Growth vs. Prev Year 92.68%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AVDL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -93.34%
Return-on-Assets % -44.77%
Profit Margin % -573.25%
Debt/Equity 0.00
Price/Sales 34.46
Price/Cash Flow N/A
Price/Book 12.90
Book Value/Share 0.77
Interest Coverage -15.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar